Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Generalized Anxiety Disorder – Current Treatment – Treatment Algorithms: Claims Data Analysis – Generalized Anxiety Disorder (US)
The use of pharmacotherapies for the treatment of generalized anxiety disorder (GAD) has grown sharply, fueled by an increasing prevalence of the disorder and constrained access to nonpharmacologic…
Opioid Addiction – Access & Reimbursement – Access & Reimbursement – Digital Therapeutics in Mental Health (US)
The rapid growth of digital therapeutic (DTx) solutions to treat medical problems, fueled by increased demand for telehealth services amid the COVID-19 pandemic, has tasked U.S. payers and pharmacy…
Opioid Addiction – Current Treatment – Current Treatment: Physician Insights – Opioid Addiction (US)
Opioid addiction is a chronic disease, generally driven by a strong and irresistible urge or craving for the intake of opioid drugs and an inability to stop despite negative consequences to health…
Attention-Deficit-Hyperactivity Disorder – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key attention-deficit/hyperactivity disorder (ADHD) patient populations…
